Procurement of Medicines under the National Program for "Diagnosis and Treatment for Rare Diseases Mucopolysaccharidosis Type II (Hunter Syndrome)"

This tender concerns the procurement of essential medicines required for the National Program dedicated to the diagnosis and treatment of Mucopolysaccharidosis Type II, also known as Hunter Syndrome. This rare genetic disorder affects multiple organs and systems, and the program aims to provide necessary therapeutic interventions to patients diagnosed with this condition. The procurement is structured as a single lot, indicating a comprehensive acquisition of the specified medications. The contracting authority seeks to ensure a stable and timely supply of these critical drugs to healthcare providers involved in the national program. Key requirements will likely include adherence to strict quality standards, compliance with pharmaceutical regulations, and the ability to deliver the medicines to designated locations within Romania. Bidders are expected to demonstrate their capacity to supply the required quantities of the specified medications, meeting all technical and legal specifications. This initiative underscores the commitment to addressing the needs of patients with rare diseases, ensuring they receive appropriate medical care and treatment through established national health programs. The successful bidder will play a crucial role in supporting the ongoing efforts to manage Hunter Syndrome effectively within the country.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Romania, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.